PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 61 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $10,807,000 | -85.9% | 600,764 | -94.4% | 0.00% | -90.0% |
| Q1 2020 | $76,470,000 | -69.2% | 10,724,999 | +3.0% | 0.02% | -61.5% |
| Q4 2019 | $248,623,000 | -9.6% | 10,411,347 | +1.5% | 0.05% | -16.1% |
| Q3 2019 | $275,013,000 | +12.1% | 10,254,078 | +13.4% | 0.06% | +14.8% |
| Q2 2019 | $245,239,000 | -22.1% | 9,039,353 | -0.4% | 0.05% | -23.9% |
| Q1 2019 | $314,863,000 | +76.8% | 9,073,882 | -0.5% | 0.07% | +57.8% |
| Q4 2018 | $178,097,000 | -25.6% | 9,123,766 | +1.5% | 0.04% | -10.0% |
| Q3 2018 | $239,420,000 | -29.7% | 8,990,639 | -0.3% | 0.05% | -34.2% |
| Q2 2018 | $340,590,000 | +15.8% | 9,017,508 | +0.1% | 0.08% | +13.4% |
| Q1 2018 | $294,154,000 | +0.8% | 9,006,515 | +50.3% | 0.07% | +4.7% |
| Q4 2017 | $291,765,000 | -1.2% | 5,993,528 | +9.7% | 0.06% | -5.9% |
| Q3 2017 | $295,164,000 | -7.0% | 5,462,947 | -3.3% | 0.07% | -9.3% |
| Q2 2017 | $317,234,000 | +49.0% | 5,647,735 | +3.9% | 0.08% | +47.1% |
| Q1 2017 | $212,936,000 | +69.4% | 5,433,434 | -3.0% | 0.05% | +59.4% |
| Q4 2016 | $125,714,000 | -10.8% | 5,602,255 | -9.8% | 0.03% | -8.6% |
| Q3 2016 | $140,979,000 | -2.0% | 6,207,775 | +1.9% | 0.04% | -5.4% |
| Q2 2016 | $143,820,000 | +6.6% | 6,094,089 | -7.9% | 0.04% | +2.8% |
| Q1 2016 | $134,951,000 | -50.1% | 6,615,240 | +25.9% | 0.04% | -49.3% |
| Q4 2015 | $270,399,000 | +2.4% | 5,255,557 | -15.1% | 0.07% | -4.1% |
| Q3 2015 | $263,961,000 | -15.3% | 6,193,354 | -9.4% | 0.07% | -7.5% |
| Q2 2015 | $311,477,000 | +35.1% | 6,838,111 | +12.6% | 0.08% | +35.6% |
| Q1 2015 | $230,553,000 | +50.8% | 6,073,581 | +12.5% | 0.06% | +47.5% |
| Q4 2014 | $152,901,000 | +21.0% | 5,399,028 | +8.0% | 0.04% | +14.3% |
| Q3 2014 | $126,381,000 | -15.5% | 4,999,252 | -2.4% | 0.04% | -12.5% |
| Q2 2014 | $149,475,000 | +5.4% | 5,122,539 | -6.4% | 0.04% | +2.6% |
| Q1 2014 | $141,774,000 | +5.6% | 5,473,939 | +4.9% | 0.04% | 0.0% |
| Q4 2013 | $134,310,000 | +1366.4% | 5,215,929 | +1423.4% | 0.04% | +1200.0% |
| Q3 2013 | $9,159,000 | -3.7% | 342,383 | -11.5% | 0.00% | 0.0% |
| Q2 2013 | $9,506,000 | – | 386,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|